Drug intelligence / Profile preview

benfotiamine + methylcobalamin + alpha lipoic acid + folic acid + chromium picolinate + inositol + pyridoxine

Development stage
Unknown
Lead developer
Sanix Formulation
Modality
Small Molecules
Administration
Oral
01

Overview

Nuviana is a multi-ingredient therapeutic formulation developed by Sanix Formulation, primarily indicated for the management of diabetic neuropathy and other nerve-related disorders. The formulation combines benfotiamine (a lipid-soluble vitamin B1 derivative), methylcobalamin (the active form of vitamin B12), alpha lipoic acid (a potent antioxidant), folic acid, chromium picolinate, inositol, and pyridoxine (vitamin B6). Together, these ingredients work synergistically to improve nerve conduction velocity, reduce oxidative stress, enhance glucose utilization, and support the regeneration of damaged nerve fibers. Benfotiamine helps prevent the formation of harmful advanced glycation end-products (AGEs) by activating the enzyme transketolase. Methylcobalamin and pyridoxine are essential for myelin sheath synthesis and neurotransmitter regulation. Alpha lipoic acid provides antioxidant protection against free radical damage and acts as a cofactor for mitochondrial enzymes, while chromium picolinate aids in maintaining glycemic control by enhancing insulin sensitivity.

Brand names
Nuviana
Other names
Nuviana-Sanix Formulation
02

Targets

PDH (Pyruvate dehydrogenase complex)Nucleotide synth (Nucleotide synthesis enzymes)TKT (Transketolase)PDXK (Pyridoxal kinase)1C metabolism (One-carbon metabolism)INSR (Insulin receptor)

Beyond the preview

Go deeper on benfotiamine + methylcobalamin + alpha lipoic acid + folic acid + chromium picolinate + inositol + pyridoxine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on benfotiamine + methylcobalamin + alpha lipoic acid + folic acid + chromium picolinate + inositol + pyridoxine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call